Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -46.476% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CCCCCCC(=O)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3CC)CC1
[b] CC(/C=C/c1cccc([N+](=O)[O-])c1)=N\NC(=O)c1ccncc1
Answer: b. CC(/C=C/c1cccc([N+](=O)[O-])c1)=N\NC(=O)c1ccncc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(/C=C/c1cccc([N+](=O)[O-])c1)=N\NC(=O)c1ccncc1
CC(/C=C/c1cccc([N+](=O)[O-])c1)=N\NC(=O)c1ccncc1
N-[(E)-[(E)-4-(3-nitrophenyl)but-3-en-2-ylidene]amino]pyridine-4-carboxamide